Fondaparinux anti-Xa activity: a comparison of one clotting assay and chromogenic substrate assays.

被引：0
|
作者：
Van Dreden, P
Depasse, F
Gerotziafas, GT
Busson, J
Fontaine, S
Samama, MM
机构：
[1] Serbio Labs, Gennevilliers, France
[2] LCL, Ivry, France
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4191
引用
收藏
页码：120B / 121B
页数：2
相关论文
共 50 条
  • [1] Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti-Xa activity
    Depasse, F
    Gerotziafas, GT
    Busson, J
    Van Dreden, P
    Samama, MM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (02) : 346 - 348
  • [2] A MECHANIZED CHROMOGENIC ASSAY FOR THE DETECTION OF ANTI-XA ACTIVITY IN PLASMA
    TENCATE, H
    LAMPING, RJ
    HENNY, CP
    PRINS, A
    TENCATE, JW
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 235 - 235
  • [3] LABORATORY VALIDATION OF A CHROMOGENIC ANTI-XA ASSAY FOR APIXABAN
    Leger, Rachel R.
    Tange, Julie I.
    McBane, Robert D.
    Chen, Dong
    Pruthi, Rajiv K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E36 - E37
  • [4] Anti-Xa activity in VTE patients treated with fondaparinux
    Ota, Satoshi
    CLINICA CHIMICA ACTA, 2015, 442 : 22 - 23
  • [5] Anti-Xa activity monitoring of the synthetic pentasaccharide Fondaparinux
    Van Dreden, P
    Fontaine, S
    Woodhams, B
    PROCEEDINGS OF THE 18TH INTERNATIONAL CONGRESS ON THROMBOSIS, 2004, : 87 - 90
  • [6] Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux
    Ikejiri, Makoto
    Wada, Hideo
    Yamaguchi, Toshio
    Miyazaki, Shinichi
    Hasegawa, Masahiro
    Wakabayashi, Hiroki
    Asanuma, Kunihiro
    Sakaguchi, Akane
    Matsumoto, Takeshi
    Ohishi, Kohshi
    Fujimoto, Naoki
    Yamada, Norikazu
    Ito, Masaaki
    Katayama, Naoyuki
    Sudo, Akihiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (05) : 554 - 559
  • [7] Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux
    Makoto Ikejiri
    Hideo Wada
    Toshio Yamaguchi
    Shinichi Miyazaki
    Masahiro Hasegawa
    Hiroki Wakabayashi
    Kunihiro Asanuma
    Akane Sakaguchi
    Takeshi Matsumoto
    Kohshi Ohishi
    Naoki Fujimoto
    Norikazu Yamada
    Masaaki Ito
    Naoyuki Katayama
    Akihiro Sudo
    International Journal of Hematology, 2016, 103 : 554 - 559
  • [8] LABORATORY VALIDATION OF EDOXABAN CALIBRATED CHROMOGENIC ANTI-XA ASSAY
    Leger, Rachel
    Tange, Julie
    Chen, Dong
    Pruthi, Rajiv
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 99 - 99
  • [9] ASSESSMENT OF APIXABAN PLASMA LEVELS BY ANTI-XA ACTIVITY TESTS: COMPARISON OF ROTACHROM AND STA LIQUID ANTI-XA ASSAYS
    Wang, Zhaoqing
    Green, George
    Connolly, Thomas
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E76 - E77
  • [10] Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux
    Yuri, Maiko
    Tabe, Yoko
    Tsuchiya, Koji
    Sadatsuki, Ryo
    Aoki, Jun
    Horii, Takashi
    Iba, Toshiaki
    Ohsaka, Akimichi
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (05) : 453 - 458
12345